Skip to main content
Mark K. Dodson
( out of 25 reviews )

Mark K. Dodson, MD

Languages spoken: English

Clinical Locations

OB-Gyn Avenues Clinic

University of Utah Health Care Avenues Clinic
801-587-2809
  • Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    July 13, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Dodson is extremely thorough, understanding and attentive. He explains everything in easy to understand language and makes me feel comfortable during during this stressful time.

    May 12, 2023
    SUGAR HOUSE HEALTH CENTER

    Hes very honest about things and explains them well. Hes the first doctor Ive had that explained to me what couldve cause my cancer the steps we can take to reduce it from happening again. Very kind and thorough

    April 12, 2023
    SUGAR HOUSE HEALTH CENTER

    You're awesome!

    March 15, 2023
    SUGAR HOUSE HEALTH CENTER

    Once the doctor came all was great. the only issue was the waiting time before he came.

    January 13, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr Dodson is extremely knowledgeable and was easy to talk with. He explained his diagnosis to me in a very thoughtful and easy to understand manor. I was very impressed - and wished he could be my primary care physician. Top notch!

    December 17, 2022
    SUGAR HOUSE HEALTH CENTER

    Dr. Dodson has always exemplified excellent care, in my experience. Ive been to more than a few doctors in my life, and Dr. Dodson has always proven himself better than anyone else. I completely trust his decisions about my care (although he still offers a choice). I appreciate his expertise and I can tell he really cares about his patients.

    November 11, 2022
    Sugar House Health Center

    Always a great interaction with Dr.Dodson and his staff!

    October 03, 2022
    EXTERNAL SITE

    I love Dr Dodson. He was informative and helpful.

    September 16, 2022
    EXTERNAL SITE

    Dr. Mark Dodson is excellent.

  • Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Gynecological Oncology

    Education history

    Fellowship Gynecolgic Oncology - Mayo Clinic Fellow
    OB/GYN - University of Mississippi Resident
    Internship OB/GYN - Charity Hospital of Louisiana Intern
    Medicine - East Tennessee State University M.D.
    Undergraduate Biology - Middle Tennessee State University B.S.

    Selected Publications

    Journal Article

    1. Baker WD, Soisson AP, Dodson MK (2013). Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. J Obstet Gynaecol Res, 39(4), 876-78.
    2. Dorais J, Dodson MK, Calvert J, Mize B, Travarelli J, Jasperson K, Peterson CM, Soisson AP (2011 Jul). Fertility-sparing management of endometrial adenocarcinoma. Obstet Gynecol Surv, 66(7), 443-51.
    3. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol, 32(4), 411-6. (Read full article)
    4. Macdonald OK, Sause WT, Lee RJ, Lee CM, Dodson MK, Zempolich K, Gaffney DK (2006). Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol, 103(2), 661-6. (Read full article)
    5. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12(1), 250-6. (Read full article)
    6. Macdonald OK, Sause WT, Lee RJ, Dodson MK, Zempolich K, Gaffney DK (2005). Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol Oncol, 99(3), 730-5. (Read full article)
    7. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L (2004). Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res, 10(8), 2681-6. (Read full article)
    8. Orr JW Jr, Montz FJ, Barter J, Schaitzberg SD, Delmore JE, Dodson MK, Gallup D, Yeh KA, Elias EG (2003). Continuous abdominal fascial closure: a randomized controlled trial of poly(L-lactide/glycolide). Gynecol Oncol, 90(2), 342-7. (Read full article)
    9. Sharp HT, Dodson MK, Draper ML, Watts DA, Doucette RC, Hurd WW (2002). Complications associated with optical-access laparoscopic trocars. Obstet Gynecol, 99(4), 553-5. (Read full article)

    Abstract

    1. Cho S, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Janat-Amsbury M (2011). Anticancer drug delivery utilizing a mucoadhesive hybrid gel for loco-regional gynecologic applications [Abstract]. 102nd annual meeting of American Association of Cancer Research, Orlando, FL.
    2. Janat-Amsbury M, Kablitz C, Gupta K, Soisson A, Peterson C, Dodson MK (2010). Nanoparticle-loaded mucoadhesviehydrogels for the local treatment of cervical cancer [Abstract]. 41st annual meeting of the society of Gynecologic Oncologists.
    3. Dodson MK, Belnap T, Sause W, Soisson A (2010). Inappropriate use of human papillomavirus testing aat time of routine Pap [Abstract]. 41st annual meeting of the Society of Gynecologic Oncologists.
    4. Soisson A, Dodson MK, Webb J, Moore H, Hunn J, Donaldson C, Belnap T, Wendt L, Alleman K, Sause W (2010). Surgical outcomes in women with endometrial carcinoma undergoing hysterectomy by a gynecoloist at a community hospital [Abstract]. 41st annual meeting of the Society of gynecologic Oncologists.
    5. Moore H, Soisson A, Dodson MK, Rowe K, Cannon-Albright L (2010). Familial clustering of endometrial cancer in a well defined population [Abstract]. 41st annual meeting of the Society of Gynecologic Oncologists.
    6. Pittman JH, Soisson AP, Dodson MK, Hunn JR, Moore H, Webb J, Soisson E, Belnap T, Alleman K, Sause W, Janat-Amsbury M (2010). Accuracy of surgical assessment of myometrial invasion in women with endometrial cancer [Abstract]. 39th Annual meeting of the Western Association of Gynecologic Oncologists, Santa Barbara, CA.
    7. Hunn J, Soisson AP, Dodson MK (2009). The immunostimulant keyhole limpet hemocyanin inhibits cervical cancer cell growth in-vitro via apoptosis and DNA double strand breaks [Abstract]. 38th annual meeting of the Western Association of Gynecologic Oncologists, Vancouver, Canada.
    8. Soisson AP, Dodson MK (2008). Differences in surgical procedures between general gynecologists and gynecologic oncologists for women with endometrial cancer [Abstract]. 36th annual meeting of the Society of Gynecologic Oncologists, Sunriver Resort, Oregon.
    9. Soisson EE, Soisson AP, Kulgren R, Dodson MK, Zempolich K, Sause W, Gaffney D, Rowe K, Alleman K, Pinto K (2007). insufficient surgical staging by general gynecologists compared to gynecologic oncologists for women with endometrial cancer [Abstract]. 36th annual meeting of the Western Association of Gynecologic Oncologists, Lake Tahoe, CA.
    10. Soisson E, Soisson AP, Zempolich K, Dodson MK, Sause W, Gaffney D, Horvath E (2006). An analysis of differences in care for women with endometrial adenocarcinoma: Surgical care by general gynecologists in the community compared to gynecologic oncologists at tertiary medical centers: Preliminary information [Abstract]. Western Association of Gynecologic Oncologists, Lake Tahoe, CA.
  • News & Podcasts